Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,435,372

« Back to Dashboard
Patent 6,435,372 protects FLOVENT HFA, ADVAIR HFA, and VENTOLIN HFA, and is included in three NDAs.

Protection for FLOVENT HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,435,372

Title: Delivery system for a medicament and method for the assembly thereof
Abstract:An indicating device for use with a dispensing device that dispenses metered dosages of a medicament from a container having a valve moveable between an open and closed position. In a preferred embodiment, the container is reciprocally moveable within the housing along a longitudinal axis. The housing preferably has a well adapted to receive a valve stem and an exhaust port. The well communicates with the port such that the metered dosage of medicament is dispensed through the port when the valve is moved to the open position. An indicator assembly comprises an indicator member that includes dosage indicia visible to a user. In a preferred embodiment, the indicator assembly is provided in an indicator module. A method for dispensing measured dosages is also provided, along with a kit capable of being assembled as an inhalation device. A delivery system having a key member and a key entry passageway is also provided.
Inventor(s): Blacker; Richard (London, CA), Engelbreth; Daniel K. (London, CA), Schmidt; James N. (London, CA)
Assignee: 1263152 Ontario Inc. (London, CA)
Application Number:09/954,428
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent Metrics:
Source: PatentQuant.com
Field: Handling
Back Citations: 238th percentile
Forward Citations: 16th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-003May 14, 2004RXYes6,435,372*PEDJul 16, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-002May 14, 2004RXYes6,435,372*PEDJul 16, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-001May 14, 2004RXYes6,435,372*PEDJul 16, 2018Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.